传染病治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00016883
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Infectious Disease Therapeutics Market Size and Share by 2031

Buy Now

2023 年传染病治疗市场规模为 1243 亿美元,预计到 2031 年将达到 1761.3 亿美元。预计 2023-2031 年期间市场复合年增长率为 4.5%。产品获批和上市数量的增加可能仍是市场的主要趋势。

传染病治疗市场分析

社会上传染病发病率不断上升,市场参与者纷纷推出治疗传染病的先进药物,政府采取的为个人提供治疗传染病的先进设施的举措正在推动市场的发展。

传染病治疗市场概况

细菌、病毒、真菌和寄生虫都是引起传染病的生物。抗生素、抗病毒药物和抗寄生虫药物是用于治疗传染病的一些药物。传染病治疗药物可以直接作用于生物体或帮助人体免疫系统抵抗感染。传染病包括艾滋病毒、结核病、疟疾、肝炎和流感等。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

传染病治疗市场:

传染病治疗市场

  • 复合年增长率(2023 - 2031)
    4.5%
  • 2023 年市场规模
    1243 亿美元
  • 2031年市场规模
    1761.3亿美元

市场动态

增长动力
  • 传染病发病率上升
  • 更加重视传染病治疗的资金和研发
未来的趋势
  • 个性化医疗中传染病的分子诊断是市场近期的趋势
机会
  • 发展中国家的机遇日益增多

关键人物;主力;重要一员

  • 辉瑞公司
  • 吉利德科学公司
  • F. 霍夫曼-罗氏有限公司
  • 盐野义制药工业株式会社
  • 拜耳公司
  • BioCryst制药公司
  • 葛兰素史克公司
  • 艾伯维公司
  • 默克公司
  • 安斯泰来制药公司

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

药物类别
  • 抗病毒物质
  • 抗菌
  • 抗真菌
指征
  • 艾滋病病毒
  • 肝炎
  • 结核
  • 流感
  • 人乳头瘤病毒
给药途径
  • 口服
  • 肠外
  • 主题
分销渠道
  • 医院药房
  • 零售药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

传染病治疗市场驱动因素和机遇

更加注重传染病治疗的资金和研发,以促进市场增长

研发是制药公司和生物制药业务的重要组成部分。研发使公司能够推出具有巨大医疗和商业潜力的多种治疗应用的新产品。此外,领先的市场参与者正在投资研发以开发增强技术并获得更多收入份额。

下表显示了美国国立卫生研究院 (NIH) 根据合同、拨款和其他资助机制对各种疾病类别和研究的年度资助情况。

 

疾病和资金

疾病/研究领域

2019 年(百万美元)

2020(百万美元)

2021 年(百万美元)

2022(百万美元)

新发传染病

 2,950

 4,867

5,069

4,318

传染性疾病

6,313

 8,301

8,599

8,019

性传播感染

 354

 394

404

419

注:考虑了货币的当前兑换率。

资料来源:年度报告和 Insight Partners 分析

厂商资助的主要项目有:

• 2022 年 6 月,葛兰素史克公司在 10 年内投资 12.1 亿美元(10 亿英镑),加快针对严重影响低收入国家的传染病的研发。研究将集中于预防和治疗疟疾、结核病、艾滋病毒(通过 ViiV Healthcare)、被忽视的热带病(NTD)和抗菌素耐药性(AMR)的新药和颠覆性疫苗。

• 2022 年 3 月,全球基金新冠疫情应对机制 (C19RM) 收到来自加拿大的 4807 万美元(6000 万加元)捐款,受到全球抗击艾滋病、结核病和疟疾基金的赞扬。新资金用于向中低收入国家提供重要的治疗和诊断测试,包括医用氧气和个人防护设备 (PPE)。

因此,对研发和资金的日益关注正在推动传染病治疗市场的增长。

发展中国家的机遇日益增多

传染病的发病率不断上升,预计将促进新兴国家传染病治疗药物的销售。由于数据要求较低且法律更为严格,亚太地区已成为一个灵活且商业友好的地区。此外,新兴国家在卫生研究和生命科学方面的大量投资在支持发展中国家的尖端技术方面发挥着重要作用,这反过来又促进了传染病检测和治疗的趋势。例如,联合国艾滋病规划署呼吁到 2025 年投资 290 亿美元,以满足中低收入国家的艾滋病预防和治疗需求。在印度、韩国、巴西和墨西哥,肝炎、HAI、HIV 和流感等传染病盛行;患者人数众多;可支配资金增加;医疗基础设施得到改善;医疗旅游业正在扩大。因此,在这些国家扩大传染病治疗市场中,基本传染病治疗产品生产商应该会在未来获得盈利前景。

传染病治疗市场报告细分分析

有助于得出传染病治疗市场分析的关键部分是药物类别、适应症、给药途径、分销渠道。

  • 根据药物类别,传染病治疗市场分为抗病毒、抗菌、抗真菌和其他药物。抗病毒药物在 2023 年占据了最大的市场份额。
  • 根据适应症,市场分为 HIV、肝炎、结核病、流感、HPV 等。HIV 领域在 2023 年占据了最大的市场份额。
  • 就给药途径而言,市场分为口服、肠外、外用和其他。口服制造商部门在 2023 年占据了最大的市场份额。
  • 根据分销渠道,传染病治疗市场分为医院药房、零售药房和其他。医院药房部门在 2023 年占据了最大的市场份额。

传染病治疗市场份额按地区分析

传染病治疗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美占据了市场主导地位。预计越来越多的技术进步和不断增加的研发活动将加速传染病治疗市场的增长。此外,大型医疗保健企业和对治疗慢性病和病毒性疾病的先进治疗解决方案的需求不断增长,正在推动该地区的市场扩张。

传染病治疗市场报告范围

报告属性细节
2023 年的市场规模1243亿美元
2031 年市场规模1761.3亿美元
全球复合年增长率(2023 - 2031)4.5%
历史数据2021-2022
预测期2024-2031
涵盖的领域按药物类别
  • 抗病毒物质
  • 抗菌
  • 抗真菌
按适应症
  • 艾滋病病毒
  • 肝炎
  • 结核
  • 流感
  • 人乳头瘤病毒
按给药途径
  • 口服
  • 肠外
  • 主题
按分销渠道
  • 医院药房
  • 零售药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 辉瑞公司
  • 吉利德科学公司
  • F. 霍夫曼-罗氏有限公司
  • 盐野义制药工业株式会社
  • 拜耳公司
  • BioCryst制药公司
  • 葛兰素史克公司
  • 艾伯维公司
  • 默克公司
  • 安斯泰来制药公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

传染病治疗市场新闻和最新发展

传染病治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。传染病治疗市场的一些发展如下所列:

  • 罗氏在接受 CE 标志的国家/地区推出了首批用于 cobas 5800 系统的传染病检测和 cobas omni–Utility Channel。cobas 5800 系统上的 cobas omni–Utility Channel 通过将开放通道检测与罗氏体外诊断 (IVD) 检测整合到一个平台上,实现了更广泛的检测菜单。(来源:F. Hoffmann-La Roche Ltd,新闻稿,2022 年 12 月)

传染病治疗市场报告覆盖范围和交付成果

“传染病治疗市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:

  • 传染病治疗市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 传染病治疗市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 传染病治疗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及传染病治疗市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors impacting the infectious diasease therapeutics market?

Rising prevalence of infectious disease and increasing focus on funding and R&D for infectious disease therapeutics are the factors driving the market.

What are the future trends of the infectious diasease therapeutics market?

Rising number of product approvals and launches is likely to act as future trends in the market.

Which are the leading players operating in the infectious diasease therapeutics market?

Pfizer Inc, Gilead Sciences Inc, F. Hoffmann-La Roche Ltd, Shionogi & Co Ltd, Bayer AG, BioCryst Pharmaceuticals Inc, GSK Plc, AbbVie Inc, Merck & Co Inc, and Astellas Pharma Inc are the leading players operating in the infectious diasease therapeutics market.

What would be the estimated value of the infectious diasease therapeutics market by 2031?

The estimated value of the market by 2031 will be US$ 176.17 billion.

What is the expected CAGR of the infectious diasease therapeutics market?

The market is estimated to grow at a CAGR of 4.5% during 2023–2031.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports